Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Moscicki previously served as the deputy center director for science operations at the FDA’s Center for Drug Evaluation and ...

The MoU underscores a shared commitment to strengthening Abu Dhabi’s position as a global hub for healthcare innovation ...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, ...

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real-world data ...

Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to add cardiometabolic assets, including weight loss therapies, to the pipeline, following a major trial setback this month.

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real ...

SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

The HIV Clinical Trials Market focuses on the systematic evaluation of novel antiretroviral therapies, combination regimens, long-acting injectables, and immunotherapeutic approaches to control and ...